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Impaired autophagic flux is associated with increased
endoplasmic reticulum stress during the development
of NAFLD
A´ Gonza´lez-Rodrı´guez1,2, R Mayoral3,4,10, N Agra2,10, MP Valdecantos1,2,10, V Pardo1,2, ME Miquilena-Colina5, J Vargas-Castrillo´n4,5,
O Lo Iacono6, M Corazzari7, GM Fimia7, M Piacentini7,8, J Muntane´4,9, L Bosca´2,4, C Garcı´a-Monzo´n*,4,5,11, P Martı´n-Sanz*,2,4,11
and A´M Valverde*,1,2,11
The pathogenic mechanisms underlying the progression of non-alcoholic fatty liver disease (NAFLD) are not fully understood.
In this study, we aimed to assess the relationship between endoplasmic reticulum (ER) stress and autophagy in human and mouse
hepatocytes during NAFLD. ER stress and autophagy markers were analyzed in livers from patients with biopsy-proven non-
alcoholic steatosis (NAS) or non-alcoholic steatohepatitis (NASH) compared with livers from subjects with histologically normal
liver, in livers from mice fed with chow diet (CHD) compared with mice fed with high fat diet (HFD) or methionine-choline-deficient
(MCD) diet and in primary and Huh7 human hepatocytes loaded with palmitic acid (PA). In NASH patients, significant increases in
hepatic messenger RNA levels of markers of ER stress (activating transcription factor 4 (ATF4), glucose-regulated protein 78
(GRP78) and C/EBP homologous protein (CHOP)) and autophagy (BCN1) were found compared with NAS patients. Likewise,
protein levels of GRP78, CHOP and p62/SQSTM1 (p62) autophagic substrate were significantly elevated in NASH compared with
NAS patients. In livers from mice fed with HFD or MCD, ER stress-mediated signaling was parallel to the blockade of the
autophagic flux assessed by increases in p62, microtubule-associated protein 2 light chain 3 (LC3-II)/LC3-I ratio and
accumulation of autophagosomes compared with CHD fed mice. In Huh7 hepatic cells, treatment with PA for 8 h triggered
activation of both unfolding protein response and the autophagic flux. Conversely, prolonged treatment with PA (24 h) induced
ER stress and cell death together with a blockade of the autophagic flux. Under these conditions, cotreatment with rapamycin or
CHOP silencing ameliorated these effects and decreased apoptosis. Our results demonstrated that the autophagic flux is
impaired in the liver from both NAFLD patients and murine models of NAFLD, as well as in lipid-overloaded human hepatocytes,
and it could be due to elevated ER stress leading to apoptosis. Consequently, therapies aimed to restore the autophagic flux
might attenuate or prevent the progression of NAFLD.
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Non-alcoholic fatty liver disease (NAFLD) is an increasingly
common chronic liver disease worldwide encompassing
from simple steatosis (non-alcoholic steatosis (NAS)) to
steatohepatitis (non-alcoholic steatohepatitis (NASH)) with
progressive fibrosis and, ultimately, cirrhosis.1,2 Although
oxidative stress and proinflammatory cytokines have relevant
roles in NASH pathogenesis, our understanding of the
molecular mechanisms involved in liver cell injury contributing
to progression from NAS to NASH is still very limited.3,4
The unfolded protein response (UPR) is an adaptive cellular
process characterized by translational arrest of protein
synthesis in the endoplasmic reticulum (ER), which when
dysregulated can perpetuate ER stress and oxidative and
inflammatory signaling, both processes known to be important
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in the pathogenesis of NASH.5 Cellular stressors initiate a
signal-transduction cascade mediated by three transmem-
brane ER sensors: PKR-like eukaryotic initiation factor 2
kinase (PERK), activating transcription factor 6 (ATF6) and
inositol requiring 1a (IRE1a). These cascades are kept
inactive as long as sensors are bound to the intraluminal
chaperone glucose-regulated protein 78 (GRP78). If the cell
fails to adapt, oxidative and inflammatory signaling pathways
are triggered, leading to apoptosis through PERK-mediated
C/EBP homologous protein (CHOP) expression, IRE1a-
mediated recruitment of tumor necrosis factor receptor-
associated factor 2 and signal-regulated kinase 1/C-jun
N-terminal kinase (JNK) (reviewed by Hotamisligil et al.6).
Autophagy, or cellular self-digestion, is a lysosomal path-
way that degrades intracellular organelles to maintain energy
homeostasis during periods of nutrient deprivation and to
remove damaged cellular components.7,8 There are three
major pathways that regulate macroautophagy. First, in
response to nutrients, phosphatidylinositol 3-kinase (PI3K)
activates the mammalian target of rapamycin (mTOR), which,
in turn, blocks autophagy through inhibition of Atg1 from
recruiting its partners Atg13 and Atg17.9 A secondary path-
way is mediated by Atg6/beclin-1, which forms a complex with
Vps34, the class III PI3K. Beclin-1 is an important interface
between autophagy and cell death pathways, because the
antiapoptotic proteins Bcl-2 and Bcl-xL bind beclin-1 to inhibit
autophagy.10 The third pathway involves Atg3- and Atg7-
mediated conjugation of microtubule-associated protein 1
light chain 3 (LC3-I) to the membrane lipid phosphatidyletha-
nolamine to form LC3-II.11 LC3-II is present on both the inner
and outer isolation membranes, serving as a recognition site
for LC3-binding chaperones such as p62/SQSTM1 (p62) that
deliver their cargo to autophagosomes.12 Once formed,
autophagosomes traffic along microtubules to reach lyso-
somes where they fuse to form autophagolysosomes allowing
the degradation of their contents by lysosomal acid
hydrolases.
The implication of autophagy in hepatocyte lipidmetabolism
has been recently demonstrated.13,14 In humans, alterations
in autophagy may have a role in the pathophysiology of
disorders that result from excessive lipid accumulation, such
as manifestations of metabolic syndrome and NAFLD. In
NAFLD, impairment in hepatocyte autophagy may not only
promote steatosis but also might lead to NASH owing to the
loss of autophagy’s protective function against cell death. The
latter hypothesis prompted us to determine the extent of ER
stress and impairment of autophagy and the pathways
involved in NAFLD patients. We have also evaluated the
relationship between lipid accumulation, ER stress and the
autophagy pathways in human hepatocytes and murine
models of hepatic steatosis and NASH.
Results
Patient characteristics. Features of NL (normal liver)
individuals and NAFLD patients studied are detailed in
Table 1. All groups were well matched in terms of age and
sex distribution. In the NAFLD cohort, NAS patients had
significantly higher body mass index (BMI) mean (P¼ 0.017),
insulin (P¼ 0.007), homeostasis model assessment of
insulin resistance (HOMA-IR) score (P¼ 0.009), triglycerides
(P¼ 0.031) and g-GT (Po0.001), as well as lower
HDL-cholesterol mean (P¼ 0.039) than subjects with NL. In
NASH patients, the BMI mean, insulin, HOMA-IR score,
triglycerides, ALT, AST and g-GT were significantly higher
than in NL individuals (Po0.001 for all). In addition,
HDL-cholesterol mean was significantly lower in NASH
patients than in NL subjects (P¼ 0.013). As expected,
NASH patients had significantly higher serum ALT than
NAS patients (Po0.001).
Hepatic autophagy is impaired in NAS and NASH
patients. First, we analyzed ER stress markers in human
liver biopsies from patients with NAFLD. Messenger RNA
(mRNA) levels of ATF4 decreased in NAS patients compared
with the other two groups (Figure 1a). Moreover, GRP78 and
CHOP mRNA levels were increased in NASH patients
compared with NAS patients or NL individuals. When protein
analysis was carried out, an increase in CHOP was detected
in NAS and NASH patients, whereas GRP78 only increased
in the NASH group (Figure 1b).
Next, we analyzed mRNA levels of autophagy mediators.
Hepatic mRNA levels of BECN1 were significantly lower in
patients with NAS as compared with individuals with NL
(Figure 1a). However, hepatic mRNA levels of the autophagic
Table 1 Demographic, metabolic, biochemical and histopathological charac-
teristics of patients with normal liver and NAFLD
Feature NL
(n¼ 34)
NAS
(n¼ 26)
NASH
(n¼23)
Age (years) 45.1±11.3 47.9±14.7 48.5±14.3
Female gender 20 (58.8%) 16 (61.5%) 14 (60.9%)
Body mass index (kg/m2) 25.8±2.4 29.2±3.1a 30.1±2.8a
Glucose (mg/dl) 92.8±4.6 96.9±7.1 96.5±7.3
Insulin (mU/l) 5.7±2.5 12.1±6.5a 15.4±5.6a
HOMA-IR 1.48±0.43 3.63±1.17a 3.92±1.54a
Triglycerides (mg/dl) 103.2±43.4 132.1±47.4a 198.1±56.1a,b
HDL-cholesterol (mg/dl) 49.1±8.2 42.2±8.7a 40.4±9.1a
ALT (IU/l) 13.9±6.6 18.8±14.6 64.2±29.2a,b
AST (IU/l) 15.5±3.5 22.6±8.7 36.8±12.4a
g-GT (IU/l) 28.1±12.4 79.2±60.4a 86.4±72.7a
Steatosis (%)
Grade 0 34 (100%)
Grade 1 11 (42.3%) 7 (30.4%)
Grade 2 9 (34.6%) 10 (43.5%)
Grade 3 6 (23.1%) 6 (26.1%)
Fibrosis (%)
Stage 0 34 (100%) 26 (100%)
Stage 1 12 (52.1%)
Stage 2 7 (30.5%)
Stage 3 4 (17.4%)
Ballooning and lobular inflammation (%)
Grade 0 34 (100%) 26 (100%)
Grade 1 7 (30.5%)
Grade 2 11 (47.8%)
Grade 3 5 (21.7%)
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransfer-
ase; g-GT, gamma-glutamyltransferase; HDL, high-density lipoprotein; HOMA-
IR, homeostatic model assessment-insulin resistant; NAS, nonalcoholic
steatosis; NASH, nonalcoholic steatohepatitis; NL, normal liver
Data are shown as mean±S.D. or as number of cases (%)
aPo0.05 with respect to NL group
bPo0.05 with respect to NAS group
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substrate SQSTM1 (p62) increased in both NAS and NASH,
although no statistical significance was found when these
patients were compared with NL individuals.
As lipidation of LC3 and its association with autophago-
some membranes has been established as useful sign
for autophagy, we detected LC3 by immunoblotting and
fluorescence microscopy. Importantly, a significant increase
in LC3-II/LC3-I ratio was detected in both NAS and NASH
patients compared with NL subjects (Figure 1b). Moreover,
LC3-II punctuate was clearly visible by immunofluorescence
in biopsies from both patient groups, whereas diffuse staining
was visualized in NL samples (Figure 1c). However, these
techniques should be analyzed carefully, as positive results
clearly indicate increased numbers of autophagosomes, but
do not always mean upregulation of the autophagic flux.8 True
autophagic function can be measured by the change in LC3-II
levels in the presence versus absence of lysosomal inhibitors,
which measures the rate of LC3-II degradation. As these
approaches were not possible in human liver samples, we
measured protein levels of p62, a selective substrate of
autophagy, because activation of the autophagic flux leads to
a decline in p62 expression, and vice versa.15,16 As Figure 1b
shows, a significant increase in p62 was detected in both NAS
and NASH patients compared with individuals with NL,
indicating impairment in the autophagic flux. Furthermore,
p62 was significantly elevated in NASH compared with NAS
patients.
Fibrogenic markers (h-COL1A1 and h-PAI1) were signifi-
cantly elevated in NASH patients compared with NL and NAS
groups. Likewise, mRNA levels of DAPK1 were exclusively
elevated in the NASH group (Figure 1a). The histological
analysis by hematoxylin/eosin (H&E) and Masson’s trichrome
staining of these representative samples is shown in
Figure 1d. The analysis of cell death by TUNEL previously
Figure 1 Hepatic autophagy flux is impaired in NAS and NASH patients. Analysis of ER stress and autophagy markers in human liver samples from NL (n¼ 34)
individuals and NAS (n¼ 26) and NASH (n¼ 23) patients. (a) qPCR analysis from all samples. The fold induction value for triplicate wells was averaged and data are
presented as mean±S.E.M. relative to NL. (b) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to all patients,
data are presented as mean±S.E.M. relative to NL. (c) Representative anti-LC3 immunostaining in liver sections. (d) Representative images from H&E and Masson’s
trichrome staining. *Po0.05, **Po0.01 and ***Po0.005, NAS or NASH, respectively, versus NL; #Po0.05, ##Po0.01 and ###Po0.005, NASH versus NAS
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reported17 revealed the presence of apoptosis only in the
NASH group.
Increased ER stress correlates with the accumulation of
p62, LC3-II and autophagosomes in livers of mice fed
with HFD or MCD. We next examined whether activation of
the ER stress signaling was accompanied by changes in the
autophagic flux during the progression of experimental
NAFLD in mice. For this purpose, male C57BL6 mice were
fed with high fat diet (HFD) for 30 weeks to generate NAS or
with methionine-choline-deficient diet (MCD) for 4 weeks as
a well-established model of NASH. Control mice were fed
with chow diet (CHD). Upon histological examination, the
livers of mice fed with HFD exhibited steatosis (Figure 2a).
Phosphorylation of PERK, eIF2a and JNK, the latter
activated via IRE,18 and CHOP protein levels were sig-
nificantly increased in mice with hepatic steatosis compared
with the control group (Figure 2b). However, protein levels of
GRP78 were similar in both groups. These results agree with
other studies.19,20 As nutrient-mediated activation of mTOR
suppresses autophagy,9 we evaluated the phosphorylation of
mTOR and its downstream target S6K1. Figure 2c shows
significant increases in both phosphorylated proteins in HFD-
fed mice compared with mice receiving CHD. Consequently,
the autophagic flux was blocked as revealed by significant
increase in levels of polyubiquitinated proteins, accumulation
of p62 and increased LC3-II/LC3-I ratio in mice fed with HFD
that was also evidenced by the increased LC3-II punctuate
in liver sections (Figures 2d–f). Electron microscopy (EM)
revealed accumulation of double membrane structures
Figure 2 Increased ER stress correlates with accumulation of p62 and LC3-II in livers of HFD-fed mice. Analysis of ER stress, autophagy and apoptosis in liver samples
from C57BL6 mice fed with CHD or HFD for 30 weeks (n¼ 8 animals per condition). (a) Representative images from H&E and Masson’s trichrome staining.
(b–e) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to all samples, data are presented as mean±S.E.M.
relative to CHD liver. (f) Representative anti-LC3 immunostaining (upper panel), EM images (middle panel) and TUNEL assay staining images (lower panel). *Po0.05 and
**Po0.01, HFD versus CHD
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(autophagosomes) in HFD-fed mice compared with control
mice (CHD). Moreover, TUNEL analysis showed the
presence of apoptotic hepatic cells only in HFD-fed mice
(Figure 2f).
Mice fed with MCD diet developed NASH manifested
by fat accumulation, ballooning and infiltration of inflamma-
tory cells in the histological evaluation (Figure 3a) and
also in the elevation of serum ALT (CHD, 30.1±2.6U/l and
MCD, 206.3±10.5U/l). As observed in HFD-fed mice,
mice fed with MCD showed elevated phosphorylation of
ER stress markers, as well as increased GRP78 and CHOP
protein expression compared with the control group
(Figure 3b). Moreover, mTOR and S6K1 phosphorylations
were elevated in livers of MCD-fed mice (Figure 3c) in
parallel to an increase in the amount of polyubiquitinated
proteins, an accumulation of p62, higher LC3-II/LC3-I ratio
and visualization of punctuate LC3-II staining and autopha-
gosomes compared with CHD controls (Figures 3d–f). These
effects were coincident with increases in apoptosis in the
MCD group as assessed by TUNEL (Figure 3f). Altogether,
these results indicate that increased ER stress, blockade of
the autophagic flux and apoptosis are hallmarks during
NAFLD.
Short-term treatment with PA induces autophagy in
human hepatic cells. We next investigated the possibility to
overcome the blockade of the autophagic flux by fatty acid
overload by performing in vitro experiments in Huh7 human
hepatic cells treated with palmitic acid (PA)21 combined
with rapamycin, a well-known inducer of autophagy.22
Figure 3 Increased ER stress correlates with accumulation of p62 and LC3-II in livers of MCD diet-fed mice. Analysis of ER stress, autophagy and apoptosis in liver
samples from C57BL6 mice fed with CHD or MCD for 4 weeks (n¼ 10 animals per condition). (a) Representative images from H&E and Masson’s trichrome staining.
(b–e) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to all samples, data are presented as mean±S.E.M.
relative to CHD liver. (f) Representative anti-LC3 immunostaining (upper panel), EM images (middle panel) and TUNEL assay staining images (lower panel). #Po0.05 and
###Po0.005, MCD versus CHD
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Surprisingly, autophagic flux was not impaired after
a short-term (8 h) treatment with PA, as assessed by
reduced phosphorylation of mTOR and S6K1 in parallel to a
decrease in p62 levels and increase in the LC3-II/LC3-I
ratio. This effect was even more pronounced than that of
rapamycin, which also activated the authophagic flux
compared with untreated cells (Figures 4a and b).
Additionally, we monitored the autophagic flux analyzing
LC3 turnover assay using bafilomycin A1, which inhibits
lysosomal function and the late degradation stage
of autophagy, thereby triggering the accumulation of
autophagosomes.16 The combination of PA and bafilomycin
A1 increased p62 expression and also induced a higher
accumulation of LC3-II compared with PA-treated cells
(Figures 4c and d). These data demonstrated that LC3-II
accumulation induced by PA results from the activation of
autophagosome formation, but not from an inhibition of the
autophagosome degradation steps.
Rapamycin prevents ER stress treatment with PA in
human hepatic cells. Regarding ER stress, PA treatment
(8 h) induced PERK, eIF2a and JNK phosphorylations in
Figure 4 Short-term treatment with PA induces autophagy in human Huh7 cells. Analysis of ER stress and autophagy markers in samples from Huh7 cells treated with PA
(P, 800mM) for 8 h with or without rapamycin (R, 25 ng/ml) or bafilomycin A1 (B, 10 nM). (a–c and e). Representative western blots with the indicated antibodies.
After densitometric analysis from blots corresponding to four independent experiments performed in triplicate, data are presented as mean±S.E.M. (d) Representative
anti-LC3 immunostaining and representative EM images. *Po0.05, **Po0.01 and ***Po0.005, P versus C or RP versus R; ##Po0.01, R versus C or RP versus P
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Huh7 cells compared with the untreated controls (Figure 4e).
This effect was accompanied by increased expression of
GRP78. Cotreatment of PA and rapamycin reduced these
events induced by PA and significantly blocked JNK
phosphorylation. These results showed that activation of
the UPR concurs with an active authophagic flux at early time
periods of saturated fatty acid loading. Notably, cell death
was not observed in Huh7 cells treated with PA for 8 h
(results not shown).
Rapamycin recovers the autophagic flux and decreases
cell death in Huh7 cells treated 24h with PA. When we
evaluated the effect of prolonged treatment (24 h) with PA in
Huh7 cells, we found that accumulation of p62 was paralleled
to an increase in the LC3-II/LC3-I ratio, reflecting a loss of the
autophagic flux (Figure 5a). This effect was similar to the
blockade of the autophagic flux induced by bafilomycin A1 or
chloroquine (CQ).16 To verify these data, we performed
LC3-II immunostaining and EM. Punctuate LC3-II was
Figure 5 Rapamycin recovers the autophagic flux after prolonged treatment with PA in human Huh7 cells and human primary hepatocytes. Analysis of autophagy-related
proteins expression in samples from Huh7 cells treated with PA (P, 800mM) for 24 h or bafilomycin A1 (B, 10 nM) or CQ (50 nM) (a and b) or treated with PA (P, 800mM) for
24 h in the absence or presence of rapamycin (R, 25 ng/ml) (c and d). (a and c) Representative western blots with the indicated antibodies. After densitometric analysis from
blots corresponding to four independent experiments performed in triplicate, data are presented as mean±S.E.M. (b and d). Representative anti-LC3 immunostaining and
EM images. (e) Analysis of autophagy-related protein expression in human primary hepatocytes treated with PA (P, 600mM) for 24 h and/or rapamycin (R, 25 ng/ml).
Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to four independent experiments performed in triplicate, data
are presented as mean±S.E.M. *Po0.05 and **Po0.01, P versus C or RP versus R; #Po0.05 and ##Po0.01, R versus C or RP versus P
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observed in Huh7 cells treated with PA for 24 h, but not in
vehicle-treated cells. In addition, a marked accumulation of
double-membrane structures containing cellular organelles
was visualized by EM in PA-treated Huh7 cells (Figure 5b).
This effect was higher in CQ-treated cells as compared with
PA, indicating a more potent inhibition of the authophagic flux
by this chemical compound.
Under these experimental conditions, rapamycin
decreased p62 and LC3-II/LC3-I ratio in PA-treated cells for
24 h as compared with cells treated with PA alone, indicating a
recovery of the authophagic flux (Figure 5c). This effect was
parallel to decreased LC3-II punctuate and accumulation of
autophagosomes as visualized in the EM images (Figure 5d).
Similar effects of PA and rapamycin were found in p62 levels
and LC3-II/LC-I ratio in primary cultures of human hepato-
cytes (Figure 5e).
During the prolonged treatment of Huh7 cells with PA, the
phosphorylation of mTOR and S6K1 remained similar to
untreated cells in contrast to the effect observed at 8 h
(Figure 6a). The ongoing ER stress activation was assessed
by the expression of GRP78 and this effect was ameliorated in
the presence of rapamycin (Figure 6b). In addition, we
evaluated the impact of the restoration of the autophagic flux
by rapamycin in apoptotic cell death and lipid accumulation.
For this purpose, Huh7 cells were treated with PA, rapamycin
or the combination of both for 24 h, and 4, 6-diamidino-2-
phenylindole (DAPI) staining of nuclei and Nile Red staining of
lipid droplets was analyzed. As depicted in Figure 6c, 24 h of
PA treatment increased the number of apoptotic nuclei as
described previously.23 Treatment with rapamycin alone did
not alter the number of apoptotic nuclei; meanwhile, cotreat-
ment with rapamycin and PA induced a significant decrease
as compared with the effect of PA alone. Conversely,
treatment with rapamycin did not modify PA-induced lipid
droplets formation (Figure 6d).
Reduction of CHOP levels decreases both blockade of
the autophagic flux and cell death triggered by
prolonged treatment with PA in Huh7 cells. To clarify if
elevated ER stress triggers disruption of the autophagy
flux, we performed experiments inhibiting ER stress by
reduction of CHOP by siRNA. As Figure 7a shows, CHOP
mRNA levels were reduced by almost 60% in Huh7 cells
treated with CHOP siRNA (siCHOP) compared with those
cells treated with a control oligo (siControl). When we
evaluated the effect of prolonged treatment with PA in Huh7
cells, we observed that silencing of CHOP reduced p62
together with LC3-II accumulation (Figure 7b). Interest-
ingly, addition of siCHOP to PA-treated cells decreased
apoptosis (Figure 7c).
Discussion
During the past recent years, it has been established that
defective autophagy promotes ER stress and insulin resis-
tance in the liver,14,24,25 whereas degradation of damaged
organelles by autophagy ameliorates liver diseases such as
ethanol-induced steatosis26,27 and HCC,28 suggesting that
autophagy could have a relevant pathogenic role in liver
diseases.
Previously, one study in human liver samples has found that
the progression from NAS to NASH was accompanied by
increased phosphorylation of JNK and increased ER stress
reflected by elevated GRP78 mRNA.5 Lake et al.29 recently
reported increased nuclear accumulation of total XBP-1
protein in NASH human livers. This paper also reported an
enrichment of upregulated genes of autophagy by performing
microarrays, although their validation was not shown. Thus, in
the present study, we have analyzed for the first time the
relationship between specific markers of ER stress and
autophagy in the liver of NAS and NASH patients in
comparison with individuals with normal liver. We found that
protein amount of p62 was accumulated within the liver of
patients with NAS or NASH in parallel with an increase in the
LC3-II/LC3-I ratio. Of note, levels of p62 were significantly
higher in NASH compared with NAS patients, suggesting that
this effect is related with the disease progression in humans.
Moreover, NASH patients displayed more elevated ER stress
markers, such as GRP78 and CHOP mRNAs, as well as
protein levels, reinforcing the notion that enhanced ER stress
within liver cells may be relevant in the progression from NAS
to NASH.
It has been shown that activation of the autophagic flux
leads to a decline in p62 expression and, contrarily, an
accumulation of p62 reflects a decrease in the autophagic
flux.15,16 When autophagy is off, LC3-II distributes diffusely
throughout the cytoplasm. However, upon induction of
autophagy, LC3-II is recruited via its lipid moiety to the inner
and outer surfaces of autophagosome membranes forming
LC3-autophagic punctuate.30 Therefore, accumulation of
LC3-II and autophagosomes, event previously interpreted
as induction of autophagy, is in fact a consequence of a
blockade of the autophagic flux.31 Therefore, it is conceivable
that the combination of elevated p62 and punctuate LC3-II,
which was observed in liver samples from both NAS and
NASH patients, could be reflecting an inhibition of autophago-
some degradation. Considering findings mentioned so far, a
potential mechanistic explanation for the pattern of p62 and
LC3-II/LC3-I ratio during the progression of NAFLD would be
that elevated ER stress due to lipid and nutrient overload
might increase accumulation of unfolded proteins and/or
damaged organelles, triggering liver injury through the
disruption of the autophagic flux and leading to apoptotic cell
death. In this regard, our previous results demonstrated that
apoptosis was evident in NASH patients.17
In the liver, persistent UPR has been described in HFD-fed
mice19 and in ob/ob mice that display hepatic steatosis,14 and
also in MCD fed mice.32–34 In the present study, we found an
accumulation of polyubiquitinated proteins in hepatocytes of
HFD- and MCD-fed mice, which probably lead to chronic
activation of the UPR, as demonstrated by elevated PERK
and eIF2a phosphorylation and increased GRP78 and CHOP
protein expression, overall reflecting ER overload. Whereas
polyubiquitinated proteins and p62 levels are commonly
increased in HFD-fed mice showing defective autophagic
function, there are studies showing both decreased35 or
increased LC3-II (Singh et al.36 and our study). Since, as
stated above, the LC3-II/LC3-I ratio by itself does not assess
the activation of the autophagic flux,16 it is possible that LC3-II
levels might vary depending on the conditions of the HFD
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intervention. Nevertheless, our data clearly show that the
autophagic flux is decreased inmice fedwith HFD aswell as in
the MCD model, leading to the accumulation of autophago-
somes, indicating for the first time that all the machinery that
connects ER stress with the blockade of the autophagic flux is
already activated in mice with hepatic steatosis. These results
may have relevant clinical implications, suggesting that
therapies aimed to restore the autophagic flux at early stages
of NAFLD, such as NAS, might ameliorate progression to
more advanced and irreversible forms of liver disease, such
as NASH.
Free fatty acid (FFA)-induced lipotoxicity has a critical role
in the pathogenesis of NAFLD (reviewed by Komatsu and
Ichimura12 and Malhi and Gores37), being saturated FFAs the
more toxic lipid species.38,39 In the present study, we found
that UPR was triggered in Huh7 human hepatic cells loaded
with PA for 8 h concomitantly with the activation of the
autophagic flux that was reflected by reduced phosphorylation
Figure 6 Rapamycin decreases cell death after prolonged treatment with PA in human Huh7 cells. Analysis of ER stress markers and apoptosis in samples from Huh7
cells treated with PA (P, 800mM) for 24 h and/or rapamycin (R, 25 ng/ml). (a and b) Representative western blots with the indicated antibodies. After densitometric analysis
from blots corresponding to four independent experiments performed in triplicate, data are presented as mean±S.E.M. (c). Representative DAPI staining images.
Quantification of fragmented nuclei after DAPI staining. Results correspond to four independent experiments performed in triplicate and are presented as mean±S.E.M.
(d) Representative Nile Red staining images. Quantification of Nile Red staining of the intracellular lipid bodies measured by flow cytometry. Results correspond to two
independent experiments performed in triplicate and are presented as mean±S.E.M. *Po0.05, **Po0.01 and ***Po0.005, P versus C or RP versus R; #Po0.05 and
###Po0.005, R versus C or RP versus P
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of mTOR and S6K1, decreased p62, increased LC3-II/LC3-I
ratio and by the effect of bafilomycin A1. These results
suggest that this early response conferred protection against
cell death as no apoptotic cells were detected at this time
period. In contrast, a more prolonged exposure of Huh7 cells
to ER stress by long PA treatment (24 h) induced cell death
manifested by the abundance of apoptotic nuclei as compared
with untreated cells. Notably, this later effect was coincident
with the visualization of a high number of autophagosomes.
These data clearly indicate that prolonged PA treatment
induced a switch to the inhibition of the autophagic flux. To our
knowledge, this is the first study that shows this transition
monitored by the sequential accumulation of the autophagic
substrate p62 between 8 and 24 h of PA exposure that was
parallel to an increase in LC3-II punctuate and, importantly, to
the induction of cell death. The fact that the reduction of the
autophagic flux in Huh7 cells and primary human hepatocytes
loaded with PA for 24 h was not accompanied by increased
mTOR/S6K1 phosphorylation is intriguing and contrasts with
our in vivo study in mice and data from Khamzina et al.40 One
possible explanation for such difference is the more complex
regulation ofmTOR-mediated signaling pathway in liver tissue
that integrates a number of signals emerging from different
non-parenchymal cell types. In addition, an mTOR-indepen-
dent regulation of autophagy and PA-mediated cell death
through the activation of protein kinase C has also been
described.41 Despite the lack of induction of mTOR phos-
phorylation by long-term treatment with PA in Huh7 cells, its
inhibition by rapamycin reactivated the autophagic flux by
decreasing p62 and the accumulation of autophagosomes
(also observed in primary human hepatocytes) and amelio-
rated PA-induced increase in apoptotic cells. Reduction of ER
stress by decreasing CHOP levels also prevented the
blockade of autophagic flux by long-term treatment with PA
and partly reduced cell death. The involvement of CHOP in ER
stress-induced autophagy and cell death agrees with
the previous data.42,43 Thus, the prosurvival function of
autophagy suggests a potential therapeutic strategy in the
protection of hepatic cells against lipotoxicity.
In conclusion, we have demonstrated that autophagic flux is
impaired in livers from both patients and murine models of
NAFLD, as well as in long-term PA-loaded human
Figure 7 Efect of silencing of CHOP on the autophagic flux and cell death after prolonged treatment with PA in human Huh7 cells. Analysis of autophagy-related proteins
expression and apoptosis in samples from Huh7 cells treated with control siRNA (siControl, 5 nM) or siCHOP (5 nM) for 36 h, followed by PA (P, 800mM) for 24 h. (a) CHOP
mRNA levels determined by real-time PCR. The fold induction value for triplicate wells was averaged and data are presented as mean±S.E.M. relative to siControl cells.
(b) Representative western blots with the indicated antibodies. After densitometric analysis from blots corresponding to three independent experiments performed in triplicate,
data are presented as mean±S.E.M. (c). Representative DAPI staining images. Quantification of fragmented nuclei after DAPI staining. Results correspond to three
independent experiments performed in triplicate and are presented as mean±S.E.M. *Po0.05, **Po0.01 and ***Po0.005, P versus C or RP versus R; #Po0.05 siCHOP
versus siControl
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hepatocytes, providing evidences that disruption of autop-
hagy could be due to elevated ER stress leading to apoptosis.
Our results strongly suggest that therapies aimed to restore
the autophagic fluxmight prevent or attenuate the progression
of NAFLD.
Materials and Methods
Reagents. Fetal bovine serum (FBS), culture media DMEM, TRIzol reagent,
SuperScript III First-Strand Synthesis System and DAPI (D1306) were obtained from
Invitrogen (Grand Island, NY, USA). PA (P0500), rapamycin, CQ, bafilomycin A1
and bovine serum albumin (BSA) were from Sigma-Aldrich (St. Louis, MO, USA).
H&E and Masson’s trichrome solutions were from Panreac Quı´mica (Barcelona,
Spain). Bradford reagent, acrylamide and Immunoblot PVDF membrane were
from Bio-Rad (Mu¨nchen, Germany). Immobilon Western Chemiluminescent HRP
Substrate was purchased from Millipore (Billerica, MA, USA).
Patients. This study comprised 49 non-diabetic patients with a clinical
diagnosis of NAFLD who underwent a liver biopsy by a percutaneous route
during programmed cholecystectomy. Inclusion criteria for NAFLD patients were
based on the absence of alcohol intake (o20 g per day), the presence of biopsy-
proven steatosis with/without necroinflammation and/or fibrosis, and no evidence
of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency
virus (HIV) infections. Patients with other causes of chronic liver disease or those
receiving potentially hepatotoxic drugs were excluded. We further studied 34
patients to whom a liver biopsy was taken during programmed laparoscopic
cholecystectomy and were diagnosed of histologically normal liver (NL). All these
NL patients had normal fasting glucose, cholesterol and triglycerides, normal
serum ALT levels, and negative anti-HBV, anti-HCV and anti-HIV tests. In addition,
all of them dranko20 g of alcohol per day and none used potentially hepatotoxic
drugs. This study was performed in agreement with the Declaration of Helsinki,
and with local and national laws. The Institution’s Human Ethics Committee
approved the study procedures, and written informed consent was obtained from
all patients before inclusion in the study.
Clinical and analytical assessment: After a 12-h overnight fast, clinical and
anthropometric data, as well as venous blood samples of each patient were
obtained at the time of liver biopsy to test serum levels of liver enzymes and
metabolic parameters. Serum insulin was determined by a chemiluminescent
microparticle immunoassay (ARCHITECT insulin; Abbot Laboratories, Abbot Park,
IL, USA). Insulin resistance was calculated by the HOMA method.44 BMI was
calculated as weight (kg) divided by height (m) squared. Antibodies against HCV
and HIV, as well as hepatitis B surface antigen were tested by immunoenzymatic
assays (Murex, Dartford, UK).
Histopathology assessment: H&E and Masson’s trichrome-stained paraffin-
embedded liver biopsy sections were evaluated by a single experienced liver
pathologist (JV-C) blinded to the clinical data. All liver biopsies measured41.5 cm
in length and showed more than 10 complete portal tracts. The percentage of
hepatocytes containing lipid droplets was determined for each 10 field. An
average percentage of steatosis was then determined for the entire specimen.
Steatosis was assessed as outlined by Kleiner et al.45 grading percentage
involvement by steatotic hepatocytes as follows: grade 0,o5%; grade 1, 5–33%;
grade 2,433–66%; and grade 3,466%.45 In addition, Brunt’s histological scoring
system was used to evaluate the degree of hepatocellular ballooning and lobular
inflammation (grade of activity), as well as the stage of fibrosis.46 These patients
were classified into two groups: those with simple steatosis (NAS) and those with
definite steatohepatitis (NASH). Minimal criteria for the histological diagnosis of
definite NASH included the combined presence of grade 1 steatosis, hepatocyte
ballooning and lobular inflammation with or without fibrosis.
Animals and diets. Male 8-week-old C57BL/6 mice purchased to Charles
River Laboratories (Charles River, Barcelona, Spain) were maintained in light/dark
(12 h light/12 h dark), temperature (22 1C) and humidity-controlled rooms with free
access to drinking water. Mice were fed with CHD (SAFE A04-10 Panlab,
Barcelona, Spain), HFD (TD-88137; Harland-Teklad, Indianapolis, IN, USA) for
30 weeks or MCD (TD-90262; Harland-Tecklad) for 4 weeks. All animal
experimentation was controlled following the recommendations of the Federation
of European Laboratory Animal Science Associations (FELASA) on health
monitoring, whereas use of animals in experimental procedures was approved by
the Consejo Superior de Investigaciones Cientı´ficas (CSIC, Madrid, Spain) Animal
Care and Use Committee.
Histopathology assessment: Paraffin-embedded liver biopsy sections (5mm)
were stained with H&E and Masson’s trichrome solution and evaluated by a
single-blinded hepatopathologist. Histopathology assessment was performed as
described above.
Determination of serum transaminase levels. Serum ALT activity
was determined using Reflotron strips (Roche Diagnostics, Barcelona, Spain), in
accordance with the manual instructions.
EM and immunofluorescence in liver samples. For EM, liver biopsies
were fixed in a glutaraldehyde (2%) plus p-formaldehyde (4%) for 60 min. Samples
were postfixed in 1% osmium tetroxide for 60 min at 25 1C, stained with uranyl
acetate (5 mg/ml) for 1 h at 25 1C, dehydrated in acetone and embedded in Epon
812 (EMbed 812; Electron Microscopy Science, Hatfield, PA, USA). Ultra-thin
sections, unstained or poststained with uranyl acetate and lead hydroxide, were
examined under a Morgagni 268D transmission electron microscope (FEI,
Hillsboro, OR, USA) equipped with a Mega View II charge-coupled device camera
(SIS, Soft Imaging System GmbH, Munster, Germany) and analyzed with
AnalySIS software (SIS). For LC3 immunostaining, paraffin-embedded liver biopsy
sections (5 mm) were stained with anti-LC3 antibody and anti-rabbit conjugate
Alexa 546. For cell death detection staining, paraffin-embedded liver biopsy sections
(5mm) were stained using DeadEnd Fluorimetric TUNEL system (Promega,
Madison, WI, USA), in accordance with the manual instructions. After corresponding
inmunostaining, liver sections were mounted with fluorescent mounting medium and
images were taken using a confocal microscope LSM710 (Zeiss, Barcelona, Spain).
Hepatocyte culture and PA treatment. Human hepatocytes were
prepared from liver biopsies obtained from 12 patients (eight males, four females
aged 58±4.0 years) submitted to a surgical resection for liver tumors after
obtaining patients’ written consent. Hepatocytes isolation was based on the two-
step collagenase procedure.47 Huh7 cell line was kindly provided by Dr. Kern
(Department of General Pathology, University Hospital Heidelberg, Heidelberg,
Germany). Huh7 cell line authentication and intraspecies cell line cross-
contamination were analyzed using Promega’s StemElite ID System (Madison,
WI, USA) for the following short tandem repeats (STRs): D21S11, TH01, TPOX,
vWA, CSF1PO, D16S539, D7S820, D13S317 and D5S818; Amelogenin was also
analyzed for gender identification together with a specific marker for mouse DNA.
STRs were analyzed with the Applied Biosystems 3130xl Genetic Analyzer in the
Genomics Core Facility of the Instituto de Investigaciones Biome´dicas Alberto Sols
CSIC-UAM. Cells were cultured in DMEM supplemented with 10% (v/v) heat-
inactivated FBS at 37 1C with 5% CO2. PA was dissolved in isopropyl alcohol at a
stock concentration of 80 mM and added to DMEM containing 1% BSA to assure a
physiological ratio between bound and unbound PA in the medium.48 The
concentration of PA used in the experiments (800mM) was similar to the fasting
PA plasma concentrations observed in human non-alcoholic steatohepatitis49,50
and was used before for mimicking hepatic lipoapoptosis.21 Confluent cells were
treated with PA (800mM) for the indicated time periods in the absence or presence
of rapamycin (25 ng/ml). Bafilomycin A1 (10 nM) and CQ (50 nM) were used as
positive control of autophagosome accumulation.
Transient transfection with siRNA. siRNA oligonucleotides were
synthesized by Dharmacon RNAi Technologies (Fisher Scientific-USA, Pittsburgh,
PA, USA) for gene silencing of human CHOP. Huh7 cells were transfected with
control or siCHOP (5 nM) following DharmaFECT General Transfection Protocol
(Dharmacon RNAi Technologies). After 36 h, cells were used for experiments.
EM and immunofluorescence in Huh7 cells. For EM, Huh7 cells were
grown in chamber slides and treated as described above. Then, cells were
washed two times with PBS, fixed in a glutaraldehyde (2%) plus p-formaldehyde
(4%) for 60 min and processed similar to liver biopsies. For LC3 immunostaining,
Huh7 cells were grown in glass coverslips and treated with PA as described in
Results and Figure legends. Then, cells were washed two times with PBS, fixed in
p-formaldehyde (4%) for 10 min and processed for LC3 immunofluorescence as
described above.
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Quantitation of apoptosis. Huh7 cells were grown in glass coverslips and
treated as described above. Then, cells were washed two times with PBS, fixed in
p-formaldehyde (4%) for 10 min and characteristic morphological changes of
apoptosis were assessed by staining nuclei with DAPI, followed by the analysis by
fluorescence microscopy.
Nile Red staining. After treatment, Huh7 cells were fixed in p-formaldehyde
(4%) and resuspended in Nile Red working solution (0.4mg/ml). The fluorescence was
determined using a FACScan flow cytometer (BD Biosciences, San Jose, CA, USA).
Quantitative real-time PCR analysis and primer sequence. Total
RNA of liver biopsy samples was extracted by using TRIzol reagent and was
reverse transcribed using a SuperScript III First-Strand Synthesis System for
quantitative real-time polymerase chain reaction (qPCR) following manufacturer’s
indications. qPCR was performed with an ABI 7900 sequence detector (Life
Technologies, Carlsbad, CA, USA) using the SYBR Green method and d(N)6
random hexamer with primers purchased from Invitrogen. PCR thermocycling
parameters were 95 1C for 10 min, 40 cycles of 95 1C for 15 s and 60 1C for 1 min.
Each sample was run in triplicate and was normalized to 18S RNA. Fold changes
were determined using the DDCt method. Primer sequences are available upon
request.
Preparation of protein extracts and western blot. Liver biopsy
samples were homogenized in a medium containing 10 mM Tris-HCl (pH 7.5),
1 mM MgCl2, 1 mM EGTA, 10% glycerol, 0.5% 3-((3-cholamidopropyl) dimethy-
lammonio)-1-propanesulfonate (CHAPS), 1 mM b-mercaptoethanol and 0.1 mM
phenylmethylsulfonyl fluoride (PMSF). To obtain total cell lysates, attached cells
were scraped off and incubated for 10 min on ice with lysis buffer (25 mM HEPES,
2.5 nM EDTA, 0.1% Triton X-100, 1 mM PMSF and 5 mg/ml leupeptin). After
protein content determination with Bradford reagent, total protein were boiled in
Laemmli sample buffer and submitted to 8–15% SDS-PAGE. Proteins were
transferred to Inmunoblot PVDF membrane, and after blocking with 3% BSA or
5% non-fat dry milk, incubated overnight with several antibodies as indicated.
Immunoreactive bands were visualized using the ECL Western blotting protocol
(Millipore). Densitometric analysis of the bands was performed using the Image J
software (NIH, Bethesda, MD, USA). Anti-phospho-PERK (Thr 980) for mouse
samples (no. 3179), anti-phospho-eIF2a (Ser 51) (no. 9721), anti-LC3 (no. 4108),
anti-phospho-mTOR (Ser 2448) (no. 2971), anti-phospho-JNK (no. 4668), anti-
S6K1 (no. 9202) and anti-ubiquitin (no. 3936) antibodies were from Cell Signaling
Technology (Boston, MA, USA). Anti-p62 (SQSTM1) antibody was from MBL
International (Woburn, MA, USA). The anti-phospho-S6K1 (Thr 389) (sc-11759),
anti-JNK (sc-571), anti-IRb (sc-711), Beclin (sc-11427), anti-phospho-PERK (Thr
980) for human samples (sc-32577), anti-PERK (sc-13073), anti-eIF2a (sc-11386),
anti-GRP78 (sc-376768), anti-CHOP for human samples (sc-575) and anti-CHOP for
mouse samples (sc-7351) were from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Anti-GAPDH antibody (AM4300) was from Ambion (Grand Island, NY,
USA). Anti-b-actin antibody (A-5441) was from Sigma Aldrich. Anti-rabbit-
conjugated Alexa 546 (A11035) was from Life Technologies (Grand Island, NY,
USA). Anti-Atg5 antibody was a gift from Dr. Patricia Boya (CSIC).
Statistical analysis. Categorical variables are presented as frequency and
percentage. Continuous variables are shown as median and range. The baseline
characteristics of the patients studied were compared by the Pearson w2 test for
categorical variables and the unpaired t-test or Mann–Whitney U-test for
continuous variables. Data from qPCR and western blotting are presented as
mean±S.E.M., and were compared by using the Bonferroni ANOVA test. All
statistical analyses were performed using the IBM SPSS Statistics 21.0 (SPSS
Inc., IBM, Armonk, NY, USA) software with two-sided tests, with a P-value of
o0.05 considered as statistically significant.
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